1 LATANOPROST | 1860 of 3890 | 1710 prescriptions Less than 1% of all prescriptions | 1710 | 420 patients 19% of all patients | 420 patients 19% of all patients | |
2 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 820 of 3120 | 710 prescriptions Less than 1% of all prescriptions | 710 | 230 patients 11% of all patients | 230 patients 11% of all patients | |
3 TIMOLOL MALEATE | 1340 of 3550 | 700 prescriptions Less than 1% of all prescriptions | | 290 patients 13% of all patients | < 11 | |
4 KETOROLAC TROMETHAMINE | 360 of 2060 | 1410 prescriptions Less than 1% of all prescriptions | 1410 | 750 patients 35% of all patients | 750 patients 35% of all patients | |
5 RESTASIS (CYCLOSPORINE) | 640 of 2510 | 310 prescriptions Less than 1% of all prescriptions | 310 | 160 patients 7% of all patients | 160 patients 7% of all patients | |
6 DORZOLAMIDE HCL | 520 of 2270 | 530 prescriptions Less than 1% of all prescriptions | | 110 patients 5% of all patients | < 11 | |
7 OFLOXACIN | 430 of 1650 | 1160 prescriptions Less than 1% of all prescriptions | 1160 | 770 patients 35% of all patients | 770 patients 35% of all patients | A |
8 DEXAMETHASONE SODIUM PHOSPHATE | 90 of 360 | 600 prescriptions Less than 1% of all prescriptions | | 290 patients 13% of all patients | < 11 | |
9 BRIMONIDINE TARTRATE | 1210 of 2910 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
10 LUMIGAN (BIMATOPROST) | 1200 of 2660 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
11 RESTASIS MULTIDOSE (CYCLOSPORINE) | 240 of 570 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
12 VALACYCLOVIR (VALACYCLOVIR HCL) | 250 of 530 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 PREDNISOLONE ACETATE | 1900 of 3470 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 ERYTHROMYCIN (ERYTHROMYCIN BASE) | 720 of 1970 | 170 prescriptions Less than 1% of all prescriptions | 170 | 150 patients 7% of all patients | 150 patients 7% of all patients | A |